Established by [region]Rhodes Island Pharmaceuticals[/region] and her partners during the early settlement of Talos-II, [nation]Endfield Industries[/nation] was founded to advance the research, exploration, and industrial development of Talos-II. Endfield plays a pivotal role in addressing the challenges posed by Talos-II, including threats such as the Aggeloi and the Blight, while pioneering technological innovations such as the Automated Industry Complex (AIC) and Protocol-Originium (PROTORIG).

